Brenda M. Luken

1.9k citations

29 papers · 1.4k indexed · h-index 20

Co-authors: David A. Lane James T. B. Crawley Sacha Zeerleder Jan Voorberg Gerben Marsman Rob Fijnheer Yaozu Xiang Rens de Groot
Topics: Complement system in diseases (17 papers)Platelet Disorders and Treatments (13 papers)Coagulation, Bradykinin, Polyphosphates, and Angioedema (9 papers)
Cited by: Hematology Immunology Genetics
Journals: Proceedings of the National Academy of Sciences Blood Science Advances
Partner nations: Netherlands United Kingdom Switzerland

In The Last Decade

Brenda M. Luken

28 papers receiving 1.4k citations

Peers

Countries citing papers authored by Brenda M. Luken

Since Specialization

Citations

This map shows the geographic impact of Brenda M. Luken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brenda M. Luken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brenda M. Luken more than expected).

Fields of papers citing papers by Brenda M. Luken

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brenda M. Luken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brenda M. Luken. The network helps show where Brenda M. Luken may publish in the future.

Co-authorship network of co-authors of Brenda M. Luken

This figure shows the co-authorship network connecting the top 25 collaborators of Brenda M. Luken. A scholar is included among the top collaborators of Brenda M. Luken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brenda M. Luken. Brenda M. Luken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Circulating Iron in Patients with Sickle Cell Disease Mediates the Release of Neutrophil Extracellular Traps 2023 ·Transfusion Medicine and Hemotherapy ·Kristof Van Avondt,(unknown),Ingrid Bulder,Gerard van Mierlo,Erfan Nur,Robin van Bruggen,Bart J. Biemond,Brenda M. Luken,Sacha Zeerleder	4
2	Impact of N-glycan mediated shielding of ADAMTS-13 on the binding of pathogenic antibodies in immune thrombotic thrombocytopenic purpura 2023 ·Journal of Thrombosis and Haemostasis ·(unknown),(unknown),(unknown),(unknown),(unknown),Brenda M. Luken,Bérangère S. Joly,Karen Vanhoorelbeke,Agnès Veyradier,Paul Coppo,Jan Voorberg	0
3	The damage-associated molecular pattern HMGB1 is released early after clinical hepatic ischemia/reperfusion 2019 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Rowan F. van Golen,Megan J. Reiniers,Gerben Marsman,Lindy K. Alles,Derrick M. Van Rooyen,Björn Petri,(unknown),Adriaan A. van Beek,Ben Meijer,M.A.W. Maas,Sacha Zeerleder,Joanne Verheij,Geoffrey C. Farrell,Brenda M. Luken,Narci Teoh,Thomas M. van Gulik,Michael P. Murphy,Michal Heger	26
4	Searching for a Common Thrombo-Inflammatory Basis in Patients With Deep Vein Thrombosis or Peripheral Artery Disease 2019 ·Frontiers in Cardiovascular Medicine ·(unknown),Simone Birocchi,René van Oerle,Sacha Zeerleder,Henri M.H. Spronk,Barend Mees,Brenda M. Luken,Hugo Ten Cate,Arina J. ten Cate‐Hoek	12
5	Dynamics of von Willebrand factor reactivity in sickle cell disease during vaso‐occlusive crisis and steady state 2017 ·Journal of Thrombosis and Haemostasis ·(unknown),(unknown),Brenda M. Luken,Erfan Nur,Sacha Zeerleder,Charlotte F.J. Van Tuijn,Dees P. M. Brandjes,(unknown),Rolf T. Urbanus,Joost C.M. Meijers,Bart J. Biemond,Karin Fijnvandraat	24
6	Coagulation factor XI improves host defence during murine pneumonia-derived sepsis independent of factor XII activation 2017 ·Thrombosis and Haemostasis ·Ingrid Stroo,Sacha Zeerleder,Chao Ding,Brenda M. Luken,Joris J. T. H. Roelofs,Onno J. de Boer,Joost C.M. Meijers,Francis Castellino,Cornelis van ′t Veer,Tom van der Poll	37
7	Extracellular histones, cell-free DNA, or nucleosomes: differences in immunostimulation 2016 ·Cell Death and Disease ·Gerben Marsman,Sacha Zeerleder,Brenda M. Luken	175
8	FSAP‐mediated nucleosome release from late apoptotic cells is inhibited by autoantibodies present in SLE 2015 ·European Journal of Immunology ·Gerben Marsman,Femke Stephan,Karina de Leeuw,Ingrid Bulder,(unknown),Jan de Jong,Johanna Westra,Irene E. M. Bultink,Alexandre E. Voskuyl,Lucien A. Aarden,Brenda M. Luken,Cees G. M. Kallenberg,Sacha Zeerleder	10
9	Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor 2011 ·Blood ·James T. B. Crawley,Rens de Groot,Yaozu Xiang,Brenda M. Luken,David A. Lane	214
10	Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura 2011 ·Haematologica ·(unknown),JN George,Sara K. Vesely,Deirdra R. Terrell,Khatira Aboulfatova,Jing Dong,Brenda M. Luken,Jan Voorberg,Ulrich Budde,Irmela Sulzer,Bernhard Lämmle,Johanna A. Kremer Hovinga	55
11	Humoral immune response to ADAMTS13 in acquired thrombotic thrombocytopenic purpura 2011 ·Journal of Thrombosis and Haemostasis ·Wouter Pos,Brenda M. Luken,Nicoletta Sorvillo,Johanna A. Kremer Hovinga,Jan Voorberg	31
12	The importance of vicinal cysteines, C1669 and C1670, for von Willebrand factor A2 domain function 2010 ·Blood ·Brenda M. Luken,(unknown),Jonas Emsley,David A. Lane,James T. B. Crawley	37
13	Activated protein C cofactor function of protein S: a critical role for Asp95 in the EGF1-like domain 2010 ·Blood ·Helena Andersson,(unknown),James T. B. Crawley,Brenda M. Luken,Sinh Tran,Björn Dahlbäck,David A. Lane,Suely M. Rezende	31
14	Extracellular control of VWF multimer size and thiol‐disulfide exchange 2008 ·Journal of Thrombosis and Haemostasis ·Brenda M. Luken	2
15	VH1‐69 germline encoded antibodies directed towards ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura 2008 ·Journal of Thrombosis and Haemostasis ·Wouter Pos,Brenda M. Luken,Johanna A. Kremer Hovinga,Ellen A.M. Turenhout,F. Scheiflinger,Jing Dong,Rob Fijnheer,Jan Voorberg	45
16	Antibodies against the CUB1-2 domains of ADAMTS13 in a patient with benign monoclonal gammopathy: no causal relationship 2007 ·Haematologica ·Niels P. Riksen,Brenda M. Luken,Ina S. Klasen,Jan Voorberg,Niels Crama,Marcel van Deuren	6
17	Multiple B‐cell clones producing antibodies directed to the spacer and disintegrin/thrombospondin type‐1 repeat 1 (TSP1) of ADAMTS13 in a patient with acquired thrombotic thrombocytopenic purpura 2006 ·Journal of Thrombosis and Haemostasis ·Brenda M. Luken,Paul Kaijen,Ellen A.M. Turenhout,Johanna A. Kremer Hovinga,Jan A. van Mourik,Rob Fijnheer,Jan Voorberg	58
18	Differential effects of the loss of intrachain- versus interchain-disulfide bonds in the cystine-knot domain of von Willebrand factor on the clinical phenotype of von Willebrand disease 2006 ·Thrombosis and Haemostasis ·(unknown),Hans L. Vos,(unknown),Brenda M. Luken,Jan Voorberg,Rogier M. Bertina,Jeroen Eikenboom	16
19	Amino acid regions 572–579 and 657–666 of the spacer domain of ADAMTS13 provide a common antigenic core required for binding of antibodies in patients with acquired TTP 2006 ·Thrombosis and Haemostasis ·Brenda M. Luken,Ellen A.M. Turenhout,Paul Kaijen,Mascha Greuter,Wouter Pos,Jan A. van Mourik,Rob Fijnheer,Jan Voorberg	50
20	The spacer domain of ADAMTS13 contains a major binding site for antibodies in patients with thrombotic thrombocytopenic purpura 2005 ·Thrombosis and Haemostasis ·Brenda M. Luken,Ellen A.M. Turenhout,Janine J. J. Hulstein,Jan A. van Mourik,Rob Fijnheer,Jan Voorberg	104

About Brenda M. Luken

Brenda M. Luken is a scholar working on Hematology, Immunology and Genetics, having authored 29 papers that have together received 1.4k indexed citations. Recurring topics across this work include Complement system in diseases (17 papers), Platelet Disorders and Treatments (13 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (9 papers). The work is most often cited by research in Hematology (720 citations), Immunology (925 citations) and Genetics (389 citations). Brenda M. Luken has collaborated with scholars based in Netherlands, United Kingdom and Switzerland. Frequent co-authors include David A. Lane, James T. B. Crawley, Sacha Zeerleder, Jan Voorberg, Gerben Marsman, Rob Fijnheer, Yaozu Xiang, Rens de Groot, Ellen A.M. Turenhout and Wouter Pos. Their work appears in journals such as Proceedings of the National Academy of Sciences, Blood and Science Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact